Institutional Fund
Sanofi
Paris, FranceCIK 11214045 filings on record
Portfolio Value
$335.96M
Q1 2026
Holdings
9
Reported positions
New Buys
1
Opened this quarter
QoQ Change
+8.2%
from $310.41M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Meiragtx Hldgs PLC31.4%
- Inhibrx Biosciences Inc23.2%
- Novavax Inc16.7%
- Anaptysbio Inc9.0%
- Agomab Therapeutics NV8.7%
- Maplight Therapeutics Inc5.5%
- Other5.5%
Portfolio Holdings
9 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Meiragtx Hldgs PLC | 12.20M | $105.63M | 31.4% | 0 | Held |
| 2 | Inhibrx Biosciences Inc | 1.16M | $77.85M | 23.2% | 0 | Held |
| 3 | Novavax Inc | 6.88M | $56.01M | 16.7% | 0 | Held |
| 4 | Anaptysbio Inc | 821.9K | $30.38M | 9.0% | 0 | Held |
| 5 | Agomab Therapeutics NV | 2.78M | $29.19M | 8.7% | +2.78M | New |
| 6 | Maplight Therapeutics Inc | 912.0K | $18.54M | 5.5% | 0 | Held |
| 7 | Immuneering Corp | 2.71M | $14.27M | 4.2% | 0 | Held |
| 8 | Eledon Pharmaceuticals Inc | 815.0K | $2.51M | 0.7% | 0 | Held |
| 9 | Q32 Bio Inc | 244.1K | $1.57M | 0.5% | 0 | Held |